STRATA Skin Sciences (SSKN) Debt to Equity (2016 - 2025)
STRATA Skin Sciences (SSKN) has disclosed Debt to Equity for 13 consecutive years, with $5.28 as the latest value for Q4 2025.
- Quarterly Debt to Equity rose 72.74% to $5.28 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.28 through Dec 2025, up 72.74% year-over-year, with the annual reading at $5.28 for FY2025, 72.74% up from the prior year.
- Debt to Equity hit $5.28 in Q4 2025 for STRATA Skin Sciences, down from $11.65 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $28.7 in Q2 2025 to a low of $0.02 in Q2 2021.
- Historically, Debt to Equity has averaged $3.2 across 5 years, with a median of $0.91 in 2023.
- Biggest five-year swings in Debt to Equity: tumbled 79.47% in 2021 and later soared 1705.29% in 2025.
- Year by year, Debt to Equity stood at $0.29 in 2021, then rose by 18.91% to $0.34 in 2022, then skyrocketed by 246.24% to $1.19 in 2023, then skyrocketed by 157.7% to $3.06 in 2024, then soared by 72.74% to $5.28 in 2025.
- Business Quant data shows Debt to Equity for SSKN at $5.28 in Q4 2025, $11.65 in Q3 2025, and $28.7 in Q2 2025.